Agenus, Inc. (AGEN) Signs Agreement with NewVac to License, Develop and Market Agenus’ Kidney Cancer Vaccine in Russia
Agenus, Inc., a biotechnology company working to develop treatments for cancers and infectious diseases, and NewVac LLC, a Russian subsidiary…